Şunu aradınız:: gauti is (Litvanca - İngilizce)

kadangi sie duomenys gauti is laisvanoriskos pranesim sistemos, nepageidaujam reakcij daznis yra nezinomas.
as these data come from the spontaneous reporting system, the frequency of the adverse reactions is unknown.

-nauji rodymai, gauti is bptd tyrim, maziau apsaugoti nuo vairi paklaid, lyginant su
-the new evidence from the gprd studies is more vulnerable to various biases, e. g.

tik pavieniai saugumo ir veiksmingumo duomenys buvo gauti is ligoni, serganci isstine skleroze bei gydom neambulatorinmis slygomis.
only sparse safety and efficacy data are available from non-ambulatory patients with multiple sclerosis.

celsentri saugumo duomenys gauti is klinikini tyrim, kuri metu 1349 ziv-1 uzsikrt pacientai vartojo bent vien celsentri doz.
the safety profile of celsentri is based on 1349 hiv-1 infected patients who received at least one dose of celsentri during clinical studies.

22 ritonavirui atspars ziv-1 buvo atrinkti in vitro ir gauti is pacient, kurie buvo gydomi terapinmis ritonaviro dozmis.
ritonavir-resistant isolates of hiv-1 have been selected in vitro and isolated from patients treated with therapeutic doses of ritonavir.

tokie rezultatai gauti is esms dl to, kad sumazjo btinyb atlikti ekstrakorporalin membranin oksigenacij, o ne dl to, kad maziau kdiki mir.
this was mainly due to a reduction in the need for ecmo, rather than a reduction in death rates.

duomenys, gauti is atviro isplstins fazs tyrimo, parodo, kad struktrini pazeidim progresavimo rodikli sumazjimas islieka 60 mnesi siame pacient pogrupyje.
data from the open-label extension phase indicate that the reduction in rate of progression of structural damage is maintained for 60 months in a subset of patients.

jis dazniausiai ruosiamas is plazmos, gautos is ne maziau kaip 1000 donor.
it is usually prepared from pooled plasma from not fewer than 1,000 donors.

remiantis poregistracinio vaisto vartojimo patirtimi, pranesta dar ir apie toliau nurodytas nepageidaujamas reakcijas (duomenys gauti is spontanini pranesim, todl negalima nustatyti si nepageidaujam reakcij daznio)
the following additional adverse reactions have been reported during post­marketing experience; they are derived from spontaneous reports for which incidences cannot be determined:

informacija, gauta is si tyrim, buvo lyginama su paskelbtomis ataskaitomis, kuriose aprasyti rezultatai, gauti istyrus sia liga sergancius negydytus pacientus.
the information from these studies was compared to published reports describing the outcome of untreated patients with the disease.

duomen, gaut is bandym su gyvnais, nepakanka vertinti gydymui nstumo metu (zr.
animal studies are insufficient with respect to pregnancy (see section 5.3) .

tirtas priesvirusinis lopinaviro aktyvumas in vitro pries 112 klinikini izoliat, gaut is pacient, kuriems gydymas vienu ar daugiau proteazs inhibitoriumi buvo neefektyvus.
the in vitro antiviral activity of lopinavir against 112 clinical isolates taken from patients failing therapy with one or more protease inhibitors was assessed.

9 atsparumas dauguma virus izoliat, gaut is pacient, kuriems raltegraviras sukl nepakankam virusologin slopinim, dl atsiradusi dviej ar daugiau mutacij buvo labai atspars raltegravirui.
resistance most viruses isolated from patients failing raltegravir had high-level raltegravir resistance resulting from the appearance of two or more mutations.

* mazesn patikimumo riba (p = 0, 95) . ** hepatito b viruso pavirsinis antigenas, gautas is mieli saccharomyces cerevisiae rekombinacins paderms 2150-2-3. ^ antigeno kiekis galutiniame produkte pagal pso (trs 673, 1992) .
* as lower confidence limit (p = 0.95) . ** surface antigen of hepatitis b virus produced from recombinant strain 2150-2-3 of the yeast saccharomyces cerevisiae. ^ quantity of antigen in the final bulk product, according to w. h. o.(trs 673, 1992)